Načítá se...
Allosteric activation dictates PRC2 activity independent of its recruitment to chromatin
PRC2 is a therapeutic target for several types of cancers currently undergoing clinical trials. Its activity is regulated by a positive feedback loop whereby its terminal enzymatic product, H3K27me3, is specifically recognized and bound by an aromatic cage present in its EED subunit. The ensuing all...
Uloženo v:
| Vydáno v: | Mol Cell |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935545/ https://ncbi.nlm.nih.gov/pubmed/29681499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2018.03.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|